Pharming (PHAR) Change in Account Payables (2020 - 2025)
Pharming (PHAR) posted Change in Account Payables of $17.8 million for Q4 2025, up 743.55% on a QoQ basis from -$2.8 million in Q4 2024, and up 743.55% year-over-year from $2.1 million in Q4 2024.
Pharming (PHAR) Change in Account Payables (2020 - 2025) Analysis & Trends
Pharming's Change in Account Payables history runs 6 years deep, the most recent figure standing at $17.8 million for Q4 2025.
- Quarterly Change in Account Payables rose 743.55% year-over-year to $17.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29.8 million (up 96.0% YoY) and the FY2025 annual result came in at $14.1 million, up 610.15% from the prior year.
- Change in Account Payables was $17.8 million for Q4 2025 at Pharming, up from -$2.8 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $17.8 million in Q4 2025 and bottomed at -$4.0 million in Q4 2021.
- A 5-year average of $2.7 million and a median of -$985884.2 in 2021 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables plunged 54795.12% — and 2025, when it soared 743.55%.
- Pharming's Change in Account Payables stood at -$4.0 million in 2021, then jumped by 58.94% to -$1.6 million in 2022, then surged by 595.62% to $8.2 million in 2023, then slumped by 133.96% to -$2.8 million in 2024, then jumped by 743.55% to $17.8 million in 2025.
- Business Quant data shows PHAR's Change in Account Payables at $17.8 million in Q4 2025, -$2.8 million in Q4 2024, and $6.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.82 Mn |
| Dec 31, 2025 | 17.82 Mn |
| Dec 31, 2024 | -2.77 Mn |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | 6.56 Mn |
| Sep 30, 2024 | 6.56 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Dec 31, 2022 | -1.65 Mn |
| Dec 31, 2022 | -1.65 Mn |
| Sep 30, 2022 | -2.33 Mn |
| Sep 30, 2022 | -2.33 Mn |
| Dec 31, 2021 | -4.01 Mn |
| Dec 31, 2021 | -4.01 Mn |
| Sep 30, 2021 | -985,884.20 |
| Sep 30, 2021 | -985,884.20 |
| Dec 31, 2020 | 7,324.24 |
| Dec 31, 2020 | 7,324.24 |